Drugs
Friday, 15 Nov 2019

Former Deputy Head of China's Drug Regulator Sentenced to 16 Years in Prison

Publisher: The Insight Partners

Wu Zhen, a former deputy head of China’s food and drug regulator, was sentenced to 16 years in prison by a Chinese court, state television reported on Friday.

Wu is one of the senior officials from the regulator who has been under investigation after a safety scandal at vaccine maker Changsheng Biotechnology Co Ltd.

The company was accused last year of falsifying data for a rabies vaccine and manufacturing an ineffective vaccine for babies, sparking widespread consumer anger.

Read here

Related Industry Updates

Cannabis Market is expected to reach US$ 1,99,504.9 million by 2028
Jan 31, 2023

GSK sells $3.35 billion stake in Unilever’s Indian business
May 07, 2020

Hikma launches Dicyclomine Hydrochloride Oral Solution
May 28, 2020

FDA Approves Harmony Biosciences' Sleep Disorder Drug
Sep 04, 2019

Acne Medication Market is expected to reach US$ 11,802.29 million by 2030
Mar 04, 2024

Sickle Cell Disease Treatment Market is expected to reach US$ 4,691.87 million by 2030
Nov 07, 2023

Glenmark Becomes the First Pharmaceutical Company in India to Receive Regulatory Approval for Oral Antiviral Favipiravir, for the Treatment of Mild to Moderate COVID-19
Jun 20, 2020

Follow us on

Related News

Medical / Dec 21, 2023

US Physiological Saline Market is expected to reach US$ 3,910.28 million by 2030

Medical / Feb 13, 2026

Alkermes Completes Avadel Deal, Expands Sleep Medicine Market Reach

Medical / Jan 02, 2023

Pulmonary Arterial Hypertension Market is expected to reach US$ 10,889.08 million by 2028

Medical / May 22, 2020

Hikma receives FDA approval for its generic Vascepa®